These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 713278)

  • 61. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 62. Can calcium, phosphate, calcium phosphate product and intact parathyroid hormone levels be appropriately controlled in dialysis patients?
    Deger SM; Mutluay R; Derici U; Mandiralioglu F; Arinsoy T; Sindel S
    Med Princ Pract; 2011; 20(1):85-9. PubMed ID: 21160221
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Osteopathy and serum parathormone and 25-hydroxycholecalciferol levels in patients on long-term haemodialysis (author's transl)].
    Zazgornik J; Kokot F; Pietrek J; Schmidt P; Kopsa H
    Wien Klin Wochenschr; 1978 Jul; 90(14):496-9. PubMed ID: 676306
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women.
    Khaw KT; Sneyd MJ; Compston J
    BMJ; 1992 Aug; 305(6848):273-7. PubMed ID: 1392857
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Circulating 1,25-dihydroxycholecalciferol after intravenous injections of 1 alpha-hydroxycholecalciferol in patients on regular haemodialysis.
    Papapoulos SE; vd Berg H; Frölich M; Valentijn RM
    Nephrol Dial Transplant; 1988; 3(5):647-50. PubMed ID: 3146722
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism.
    Gray RW; Wilz DR; Caldas AE; Lemann J
    J Clin Endocrinol Metab; 1977 Aug; 45(2):299-306. PubMed ID: 885994
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Parathyroid hormone secretion and 25-hydroxyvitamin D levels in primary osteoporosis.
    Dequeker J; Bouillon R
    Calcif Tissue Res; 1977 May; 22 Suppl():495-6. PubMed ID: 912573
    [No Abstract]   [Full Text] [Related]  

  • 68. Effect of rapid variation of renal function on plasma calcitonin and parathyroid hormone in man.
    Fuss M; Bergans A; Geurts J; Brauman H; Corvilain J
    Acta Endocrinol (Copenh); 1979 Sep; 92(1):130-7. PubMed ID: 386684
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Parathyroid hormone suppression by cimetidine in the uremic patient.
    Beehler CJ; Beckner JR; Rosenquist RC; Shankel SW
    Ann Intern Med; 1980 Dec; 93(6):840-1. PubMed ID: 7447192
    [No Abstract]   [Full Text] [Related]  

  • 70. Maternal and fetal serum 1,25-dihydroxyvitamin D levels at term.
    Fleischman AR; Rosen JF; Cole J; Smith CM; Deluca HF
    J Pediatr; 1980 Oct; 97(4):640-2. PubMed ID: 6968348
    [No Abstract]   [Full Text] [Related]  

  • 71. Serum 25-hydroxyvitamin D in infantile rickets.
    Arnaud SB; Stickler GB; Haworth JC
    Pediatrics; 1976 Feb; 57(2):221-5. PubMed ID: 175345
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency.
    Soliman AT; Al Khalaf F; Alhemaidi N; Al Ali M; Al Zyoud M; Yakoot K
    Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serum-25-hydroxyvitamin-D concentrations in adolescent boys.
    Ellis G; Woodhead JS; Cooke WT
    Lancet; 1977 Apr; 1(8016):825-8. PubMed ID: 67336
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serum 25-hydroxyvitamin D levels in normal subjects: seasonal variations and relationships with parathyroid hormone and osteocalcin.
    Benucci A; Tommasi M; Fantappié B; Scardigli S; Ottanelli S; Pratesi E; Romano S
    J Nucl Biol Med (1991); 1993 Jun; 37(2):77-82. PubMed ID: 8373837
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Results of long-term treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS; Eriksson S; Lindholm TC
    Ital J Orthop Traumatol; 1984 Jun; 10(2):187-201. PubMed ID: 6432736
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serum 25-hydroxyvitamin D concentrations in sudden infant death syndrome.
    Hillman LS; Erickson M; Haddad JG
    Pediatrics; 1980 Jun; 65(6):1137-9. PubMed ID: 6966389
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis.
    Hahn TJ; Squires AE; Halstead LR; Strominger DB
    J Pediatr; 1979 Jan; 94(1):38-42. PubMed ID: 758419
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels in paretic dairy cows.
    Horst RL; Jorgensen NA; DeLuca HF
    Am J Physiol; 1978 Dec; 235(6):E634-7. PubMed ID: 252889
    [No Abstract]   [Full Text] [Related]  

  • 79. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
    Sebert JL; Marie A; Kuntz D; Marie P; Gueris J; Smadja A; Fournier A; Quichaud J
    Rev Rhum Mal Osteoartic; 1981; 48(7-9):535-41. PubMed ID: 7291931
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.